Acute myocardial infarction in a patient with hemophilia A and factor V Leiden mutation

Meral Günaldi; Aysen Helvaci; Naciye Demirel Yildirim; Muharrem Kiskaç; Reyhan Diz Küçükkaya

Vol 16, No 5 (2009)

Case Reports

Submitted: 2013-01-14

Published online: 2009-07-31

View PDF

Download PDF file

Get Citation

Acute myocardial infarction in a patient with hemophilia A and factor V Leiden mutation

Meral Günaldi, Aysen Helvaci, Naciye Demirel Yildirim, Muharrem Kiskaç, Reyhan Diz Küçükkaya

Cardiol J 2009;16(5):458-461.

Vol 16, No 5 (2009)

Case Reports

Submitted: 2013-01-14

Published online: 2009-07-31

Abstract

Factor VIII:C, epsilon amino-caproic acid or tranexamic acid are prophylactic agents used in preventing hemorrhage pre-operatively in patients with hemophilia A. Although hemophilia A seems to be a factor that avoids the development of acute myocardial infarction (AMI) as it tends to be associated with increased bleeding, it should be kept in mind that prothrombotic agents used pre-operatively for prophylaxis may increase the risk for AMI in the presence of the factor V Leiden mutation. In this report, we discuss the development of AMI following the use of recombinant factor VIII and tranexamic acid for prophylaxis in a patient with known hemophilia before a tooth extraction in conjunction with the relevant literature.